Lantheus Holdings
LNTH · NASDAQ
About LNTH
- Employees
- 1,193
- Headquarters
- North Billerica, Massachusetts
- Listed
- Jun 25, 2015
- Sector
- Health Care
- Industry
- Health Care Equipment & Supplies
- Website
- lantheus.com
LNTH key statistics
- Market cap
- 6.52B
- Price-earnings ratio
- 24.19
- Dividend yield
- —
- Average volume
- 1.05M
- Volume
- 1.33M
- Open price
- $100.07
- High today
- $100.40
- Low today
- $99.81
- 52 Week high
- $111.86
- 52 Week low
- $50.16
Lantheus Holdings (LNTH) at a glance
As of Oct 20, 2026, Lantheus Holdings (LNTH) shares are priced at $100.39, giving the company a market cap of 6.52B and a price-to-earnings ratio of 24.19.
Today the stock has traded between $99.81 and $100.40. The current price is 0.6% above the day's low and 0.0% below its high.
Volume so far is 1.33M shares, above the average of 1.05M shares a day.
Over the past year Lantheus Holdings has ranged from $50.16 to $111.86, and now sits 81% of the way up that range.
Lantheus Holdings met or beat analyst EPS estimates in 5 of the last 8 quarters. In Q2 FY26 it reported $1.55 per share against an estimate of $1.33.
The average analyst price target is $105.62, 5.2% above the current price, from 7 recent ratings.
Analyst ratings
Latest rating from each analyst over the past 12 months
- Buy28.6%
- Hold71.4%
- Sell0.0%
- Low
- $70.70
- Now
- $100.39
- High
- $120.75
LNTH earnings
Earnings per share, reported against the analyst estimate
Beat the estimate in 5 of the last 8 quarters, by 16.3% on average.
- Q3 FY24: reported $1.70 per share against an estimate of $1.59
- Q4 FY24: reported $1.59 per share against an estimate of $1.56
- Q1 FY25: reported $1.53 per share against an estimate of $1.69
- Q2 FY25: reported $1.57 per share against an estimate of $1.71
- Q3 FY25: reported $1.27 per share against an estimate of $1.29
- Q4 FY25: reported $1.67 per share against an estimate of $1.19
- Q1 FY26: reported $1.46 per share against an estimate of $1.26
- Q2 FY26: reported $1.55 per share against an estimate of $1.33
LNTH news
- Press releasePRNewswire
- Press releasePRNewswire
ACT NOW - The M&A Class Action Firm Is Investigating the Merger -- FHB, INDV, ITGR, and LNTH
- Press releasePRNewswire
Are LNTH, ITGR, CZR Obtaining Fair Deals for their Shareholders?
- Press releaseBusiness Wire
Lantheus Holdings Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Lantheus Holdings, Inc. - LNTH
- Press releaseBusiness Wire
LNTH Stock Alert: Halper Sadeh LLC is Investigating Whether Lantheus Holdings, Inc. is Obtaining a Fair Price for its Shareholders
- Vandana Singh
FDA Approves Lantheus Imaging Drug for Alzheimer's Diagnostics
- Press releasePRNewswire
Are DSGR, LNTH, ATKR Obtaining Fair Deals for their Shareholders?
- Press releaseBusiness Wire
Lantheus Holdings Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Lantheus Holdings, Inc. - LNTH
Similar companies
Companies in the same industry as Lantheus Holdings
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0003−16.67%
- SEIISharing Economy International$0.0004+100.00%
- NWGLCL Workshop Group$0.1522+27.90%
- TMSHTrans Global Assets$0.0002+0.00%
- AEFIAmerican EcoFuels$0.0007+0.00%
- CBDW1606$0.0002+0.00%
- FITYFifty 1 Labs$0.0001−66.67%
- PRSOPeraso$0.5914+54.13%
- FRTTFort Technology$0.7121+32.63%
- SDSTStardust Power$0.02−23.66%
- SHFSSHF Holdings$0.0899−4.36%
- CBDLCBD Life Sciences$0.0002−25.00%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.56+1.54%
- CTYCITY THERAPEUTICS$20.83−2.94%
- IAMIambic Therapeutics$16.01−2.02%
- AMROAmaero$5.68+1.25%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.28−0.10%
- TRXBTRex Bio$14.44−2.43%
- RTSNRetension Pharmaceuticals$16.18−0.92%
- PAXGUPine Tree Acquisition$9.98+0.00%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.18+3.39%
- ACCVAccelevation Holdings$12.31−1.44%
- RZAIROZE AI$10.28+1.28%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.